Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-25 @ 8:34 PM
Study NCT ID:
NCT05817669
Status:
COMPLETED
Last Update Posted:
2025-07-18
First Post:
2023-02-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-02-01
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-30
Results First Submit QC Date:
None
Results First Post Date:
2025-07-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-30
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL